PedAM
Pediatric Disease Annotations & Medicines
| Disease | thrombocytosis |
| Phenotype | C1292778|chronic myeloproliferative disorder |
| Sentences | 3 |
| PubMedID- 20586925 | Background: anagrelide is a selective inhibitor of megakaryocytopoiesis used to treat thrombocytosis in patients with chronic myeloproliferative disorders. |
| PubMedID- 24744668 | In patients with thrombocythemia associated with chronic myeloproliferative disorders, increased hematocrit and viscosity aggravate the platelet-mediated microvascular ischemic and thrombotic syndrome of thrombocythemia to major arterial and venous thrombotic complications. |
| PubMedID- 20681462 | In the czech republic, anagrelid is used according to the recommendations of the czech working group on myeloproliferative disorders for treatment ofthrombocythaemias associated with chronic myeloproliferative disorders--mainly essential thrombocythaemia and, regularly, reports are being presented from the register of patients treated with thromboreductin, most recently last year (vnitr lek 2009; 55: i-xii). |
Page: 1